8.19
price up icon1.74%   0.14
after-market 시간 외 거래: 7.90 -0.29 -3.54%
loading
전일 마감가:
$8.05
열려 있는:
$7.95
하루 거래량:
1.43M
Relative Volume:
1.06
시가총액:
$1.12B
수익:
$175.51M
순이익/손실:
$-78.02M
주가수익비율:
-15.45
EPS:
-0.53
순현금흐름:
$-34.18M
1주 성능:
-3.87%
1개월 성능:
+3.02%
6개월 성능:
+15.03%
1년 성능:
+61.22%
1일 변동 폭
Value
$7.93
$8.205
1주일 범위
Value
$7.93
$8.645
52주 변동 폭
Value
$4.71
$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Name
명칭
Aurinia Pharmaceuticals Inc
Name
전화
250-744-2487
Name
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
Name
직원
300
Name
트위터
@AuriniaPharma
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
AUPH's Discussions on Twitter

AUPH을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AUPH
Aurinia Pharmaceuticals Inc
8.19 1.12B 175.51M -78.02M -34.18M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-11-04 다운그레이드 Oppenheimer Outperform → Perform
2022-05-05 재개 Cantor Fitzgerald Overweight
2021-12-10 업그레이드 Oppenheimer Perform → Outperform
2021-10-28 다운그레이드 Oppenheimer Outperform → Perform
2021-01-25 재확인 H.C. Wainwright Buy
2020-11-03 재확인 H.C. Wainwright Buy
2020-06-17 개시 BTIG Research Buy
2020-05-05 개시 Cowen Outperform
2020-01-10 개시 Jefferies Buy
2019-12-16 재확인 H.C. Wainwright Buy
2018-03-16 재확인 Cantor Fitzgerald Overweight
2018-02-08 개시 RBC Capital Mkts Outperform
2017-10-30 재확인 H.C. Wainwright Buy
2017-05-18 재확인 H.C. Wainwright Buy
2017-04-11 개시 Cantor Fitzgerald Overweight
2017-03-22 재확인 FBR & Co. Outperform
2016-12-30 재확인 H.C. Wainwright Buy
2016-08-17 재확인 H.C. Wainwright Buy
2016-06-30 개시 H.C. Wainwright Buy
2015-05-08 개시 MLV & Co Buy
모두보기

Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스

pulisher
Apr 02, 2025

Declining Stock and Decent Financials: Is The Market Wrong About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)? - Yahoo Finance

Apr 02, 2025
pulisher
Apr 01, 2025

Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues - simplywall.st

Apr 01, 2025
pulisher
Mar 25, 2025

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

(AUPH) Trading Signals - news.stocktradersdaily.com

Mar 25, 2025
pulisher
Mar 10, 2025

Aurinia Pharmaceuticals Announces Financial Growth and Pipeline Progress in 2024 - Zenopa

Mar 10, 2025
pulisher
Mar 09, 2025

Principal Financial Group Inc. Sells 1,325 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Aurinia Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 08, 2025

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome - MarketScreener

Mar 08, 2025
pulisher
Mar 07, 2025

Aurinia Pharmaceuticals’ chief medical officer sells shares worth $68,350 - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Aurinia Pharmaceuticals’ chief medical officer sells shares worth $68,350 By Investing.com - Investing.com UK

Mar 07, 2025
pulisher
Mar 07, 2025

Commit To Purchase Aurinia Pharmaceuticals At $7, Earn 17.4% Annualized Using Options - Nasdaq

Mar 07, 2025
pulisher
Mar 06, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point - Yahoo Finance

Mar 06, 2025
pulisher
Mar 05, 2025

Aurinia Pharmaceuticals stock climbs on insider buying - MSN

Mar 05, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals COO Donley sells shares worth $994,424 By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals CEO Peter Greenleaf sells shares worth $2.87 million - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals’ chief medical officer sells $97,912 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals COO Donley sells shares worth $994,424 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals EVP Stephen Robertson sells shares worth $975,223 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock? - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Objective long/short (AUPH) Report - Stock Traders Daily

Mar 04, 2025
pulisher
Mar 03, 2025

LAWSUITS FILED AGAINST ABBV, SDIG and AUPHJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Atria Wealth Solutions Inc. Buys Shares of 15,000 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Simply Wall St

Mar 02, 2025
pulisher
Mar 02, 2025

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Canada Finance

Mar 02, 2025
pulisher
Feb 28, 2025

IFP Advisors Inc Raises Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Sees Strong Trading Volume Following Strong Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations - Benzinga

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia: Q4 Earnings Snapshot - CT Insider

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Aurinia Pharmaceuticals Q4 2024 misses EPS forecast - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises -February 27, 2025 at 09:26 am EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Strong Financial Growth in 2024 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (AUPH) Aurinia Pharmaceuticals Reports Q4 Revenue $59.9M, vs. FactSet Est of $60.1M - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $0.01, vs. FactSet Est of $0.02 Loss - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharma earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress - Business Wire

Feb 27, 2025
pulisher
Feb 25, 2025

High Growth Tech Stocks In The United States Spotlighting Three Leaders - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Insider Monkey

Feb 25, 2025

Aurinia Pharmaceuticals Inc (AUPH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):